FTXH was created on 2016-09-20 by First Trust. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 21.66m in AUM and 51 holdings. FTXH tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth.
First Trust Nasdaq Pharmaceuticals ETF Información sobre dividendos
First Trust Nasdaq Pharmaceuticals ETF tiene un dividendo anual de 0.00 por acción, con un rendimiento del 0.00%. El dividendo se paga trimestralmente y la última fecha ex-dividendo fue Dec 12, 2025.